Literature DB >> 6864534

Antitussive effect of the optical isomers of mu, kappa and sigma opiate agonists/antagonists in the cat.

T T Chau, F E Carter, L S Harris.   

Abstract

The optical isomer of mu and kappa opiates, when given i.v., inhibited the cough reflex in the lightly anesthetized cat, the levoisomers being, in general, 2 to 14 times more potent than the dextro-isomers. The optical isomers of the sigma agonist, SKF 10,047, did not show any antitussive activity up to near lethal or lethal doses (5 mg/kg i.v.). Naloxone (1 mg/kg i.v.) did not block or reverse the antitussive effects of (-)- and (+)-codeine but completely antagonized the effects of an ED84 of (-)-, (+)-morphine, (-)-, (+)-methadone, levomethorphan and dextromethorphan. The cough suppressant effects of the kappa opiates were partially blocked by naloxone, (+/-)-ketocyclazocine being more sensitive to the effect of naloxone than (-)-cyclazocine. (-)-SKF 10,047 at 3.0 mg/kg i.v. and the ED16 of (-)-cyclazocine did not inhibit the antitussive effect of codeine but blocked that of morphine, behaving like naloxone. (+)-SKF 10,047 and (+)-cyclazocine did not show in vivo antagonistic effect vs. codeine or morphine. The ED16 of ketocyclazocine partially antagonized codeine but not morphine. The optical isomers of opiates showed good correlation between the in vivo antitussive potencies and their in vitro inhibitory potencies against (-)-codeine binding in homogenates of the guinea-pig medulla. The data confirm the hypothesis that the cough suppressant effects of opiates are mediated by receptors which are less stereoselective and less naloxone-sensitive than the analgesic receptors. The possible involvement of mu and kappa sites as well as their interactions are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6864534

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Pharmacologic management of cough.

Authors:  Donald C Bolser
Journal:  Otolaryngol Clin North Am       Date:  2010-02       Impact factor: 3.346

2.  The effects of naloxone on opiate and placebo analgesia in healthy volunteers.

Authors:  J Posner; C A Burke
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.

Authors:  G F Steinfels; S W Tam; L Cook
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  Central mechanisms II: pharmacology of brainstem pathways.

Authors:  D C Bolser
Journal:  Handb Exp Pharmacol       Date:  2009

5.  Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats.

Authors:  Anjali Priyadarshani; Krishna Chuttani; Gaurav Mittal; Aseem Bhatnagar
Journal:  J Ovarian Res       Date:  2010-04-27       Impact factor: 4.234

Review 6.  Current and future centrally acting antitussives.

Authors:  Donald C Bolser
Journal:  Respir Physiol Neurobiol       Date:  2006-03-06       Impact factor: 1.931

7.  Antitussive activity of sigma-1 receptor agonists in the guinea-pig.

Authors:  Claire Brown; Malika Fezoui; William M Selig; Carl E Schwartz; James L Ellis
Journal:  Br J Pharmacol       Date:  2003-12-22       Impact factor: 8.739

8.  Microinjection of codeine into the region of the caudal ventral respiratory column suppresses cough in anesthetized cats.

Authors:  Ivan Poliacek; Cheng Wang; Lu Wen-Chi Corrie; Melanie J Rose; Donald C Bolser
Journal:  J Appl Physiol (1985)       Date:  2010-01-21

9.  Central and peripheral mechanisms of narcotic antitussives: codeine-sensitive and -resistant coughs.

Authors:  Kazuo Takahama; Tetsuya Shirasaki
Journal:  Cough       Date:  2007-07-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.